Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
35
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
21
users have liked this narrative
12
users have commented on this narrative
26
users have followed this narrative
13 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
MAHLE Metal Leve
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Emerging Markets And Aftermarket Trends Will Drive Future Value
Key Takeaways Strong vehicle production growth, aftermarket expansion, and favorable government policies are driving stable, recurring revenues and improved margin outlook for MAHLE Metal Leve. Strategic R&D investment, premium product focus, and geographic diversification are increasing pricing power while minimizing exposure to external market volatility.
View narrative
R$31.25
FV
13.1% undervalued
intrinsic discount
4.97%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
11 days ago
author updated this narrative
Mahindra Holidays & Resorts India
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Indian Tourism Investment And Digital Platforms Will Drive Leisure Travel
Key Takeaways Long-term growth is supported by rising domestic demand, digital customer acquisition, and capital-light expansion strategies to boost both recurring revenues and profitability. Focus on sustainability, quality upgrades, and curated experiences is expected to improve customer retention and increase member lifetime value, enhancing margins.
View narrative
₹510.00
FV
29.4% undervalued
intrinsic discount
-10.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
11 days ago
author updated this narrative
BWP Trust
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Suburban Retail Will Stumble Amid E-Commerce And Bunnings Challenges
Key Takeaways BWP Trust faces risks from reliance on Bunnings, limited diversification, and shifts toward e-commerce and smaller retail formats reducing demand for its properties. Rising interest rates, increased capital expenditures, and changing retailer strategies threaten earnings stability, net margins, and long-term asset values.
View narrative
AU$3.86
FV
5.0% undervalued
intrinsic discount
2.90%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
6
users have followed this narrative
11 days ago
author updated this narrative
Pharma Mar
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
EMA Approval And Global Launch Will Expand Oncology Markets
Key Takeaways Expanding product launches, strategic global partnerships, and strong R&D investments position PharmaMar for sustained growth and diversified revenue streams despite competitive pressures. Advances in marine-derived oncology therapies and inclusion in clinical guidelines enhance market relevance, supporting higher margins and long-term earnings potential.
View narrative
€104.60
FV
21.2% undervalued
intrinsic discount
39.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
18
users have followed this narrative
11 days ago
author updated this narrative
Afry
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Decarbonization And Asian Renewables Will Drive Future Energy Demand
Key Takeaways Rising global decarbonization and infrastructure trends, plus expansion in growth markets, are driving robust demand and revenue diversification for AFRY across energy and industrial sectors. Restructuring, portfolio optimization, and a focus on high-value consulting are expected to strengthen efficiency, margin quality, and recurring revenue streams.
View narrative
SEK 213.75
FV
28.0% undervalued
intrinsic discount
3.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
11 days ago
author updated this narrative
Fineotex Chemical
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Eco-Friendly Manufacturing And UK Agreements Will Expand Global Reach
Key Takeaways Expansion into sustainable, high-value products and end markets is driving revenue growth, margin improvement, and increased revenue diversification. Strong financial position supports ongoing R&D, international growth, and potential acquisitions, enhancing long-term earnings and valuation potential.
View narrative
₹294.00
FV
14.4% undervalued
intrinsic discount
18.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
22
users have followed this narrative
11 days ago
author updated this narrative
ZAG
Zumtobel Group
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Recovery In Non-Residential Construction And New Products Will Improve Future Prospects
Key Takeaways Strategic focus on renovation and maintenance, along with new product introductions, positions for recovery in non-residential construction, boosting future revenue and margins. Long-term contracts and key accounts provide revenue stability and visibility, mitigating demand volatility and potentially improving earnings.
View narrative
€5.10
FV
14.6% undervalued
intrinsic discount
1.13%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
11 days ago
author updated this narrative
Vitalhub
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
NHS Funding And Acquisitions Will Transform Healthcare Systems
Key Takeaways Rising healthcare digital investment and regulatory trends reinforce Vitalhub's SaaS model, platform integration, and recurring revenue momentum. Strategic acquisitions broaden product reach and geographic diversification, boosting cross-selling, margin expansion, and long-term earnings growth.
View narrative
CA$15.53
FV
11.4% undervalued
intrinsic discount
23.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
19
users have followed this narrative
11 days ago
author updated this narrative
Taaleri Oyj
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Renewable And Bioindustry Trends Will Shape A Risky Future
Key Takeaways Strong demand for renewable energy and bioindustry assets is fueling sustained management fee growth and supporting diversification into new, high-margin segments. Enhanced distribution to institutional and international investors, alongside green investment momentum, positions the company for broader market growth and recurring revenue gains.
View narrative
€9.10
FV
18.1% undervalued
intrinsic discount
0.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
11 days ago
author updated this narrative
Value any company in seconds
Popular companies